Skip to content

Phase I study of AZD9592 in solid tumors

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-501570-18-00
Acronym
D9350C00001
Enrollment
145
Registered
2023-05-17
Start date
2023-07-18
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypopharynx or larynx, Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, oropharynx, Recurrent or metastatic Head and NeckSquamous Cell Carcinoma of the oral cavity

Interventions

None listed

Sponsors

Astrazeneca AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Italy, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026